Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
| Vertex Pharmaceuticals Incorporated |
| Lupin Limited and Lupin Pharmaceuticals, Inc. |
| 1:2022cv00966 |
| July 22, 2022 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 16, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Filing 12 ANSWER to #1 Complaint, and COUNTERCLAIMS against All Plaintiffs, by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) Modified on 9/17/2022 (nms). |
| Filing 11 STIPULATION for Extension of Time - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Parshall, Jonathan) Modified on 8/17/2022 (nms). |
SO ORDERED, re #11 STIPULATION for Extension of Time (*Reset Answer Deadlines: Lupin Limited answer due 9/16/2022; Lupin Pharmaceuticals, Inc. answer due 9/16/2022). Signed by Judge Richard G. Andrews on 8/17/2022. (nms)
|
| Filing 10 NOTICE of Appearance by Francis J. Murphy, Jr on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Murphy, Francis) |
| Filing 9 NOTICE of Appearance by Jonathan L. Parshall on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Parshall, Jonathan) |
| Filing 8 DECLARATION of Mailing, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 8/1/2022 (nms). |
| Filing 7 SUMMONS Returned Executed by Vertex Pharmaceuticals Incorporated. Lupin Pharmaceuticals, Inc. served on 7/27/2022, answer due 8/17/2022. (Blumenfeld, Jack) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued as to Lupin Limited on 7/22/2022; Lupin Pharmaceuticals, Inc. on 7/22/2022. (Attachments: #1 Summons)(mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vertex Pharmaceuticals Incorporated. (mpb) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/10/2022. Date of Expiration of Patent: 2/27/2033 and 8/13/2029.Thirty Month Stay Deadline: 12/10/2024. (mpb) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,883,206 B2 ;10,272,046 B2 ;10,646,481 B2 ;11,147,770 B2. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3921217.) - filed by Vertex Pharmaceuticals Incorporated. (Attachments: #1 Exhibit A-C, #2 Exhibit D, #3 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
